MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors

被引:0
|
作者
Bernardo L. Rapoport
Ronald Anderson
Tim Cooksley
Douglas B. Johnson
机构
[1] University of Pretoria,Department of Immunology, Faculty of Health Sciences
[2] The Medical Oncology Centre of Rosebank,Department of Medicine
[3] Manchester University Foundation Trust,undefined
[4] The Christie,undefined
[5] University of Manchester,undefined
[6] Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center,undefined
来源
Supportive Care in Cancer | 2020年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6107 / 6110
页数:3
相关论文
共 50 条
  • [41] Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
    Gan, Linyang
    Chen, Huan
    Liu, Xiaowei
    Zhang, Li
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Immune-related adverse events of immune checkpoint inhibitors: a brief review
    Myers, G.
    CURRENT ONCOLOGY, 2018, 25 (05) : 342 - 347
  • [43] Advances on immune-related adverse events associated with immune checkpoint inhibitors
    Yong Fan
    Yan Geng
    Lin Shen
    Zhuoli Zhang
    Frontiers of Medicine, 2021, 15 (01) : 33 - 42
  • [44] Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors
    Suijkerbuijk, Karijn P. M.
    Kapiteijn, Ellen
    Verheijden, Rik J.
    JAMA ONCOLOGY, 2020, 6 (08) : 1300 - +
  • [45] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [46] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [47] Chronic gastrointestinal immune-related adverse events in patients exposed to immune checkpoint inhibitors
    Jeay, Marine
    Carbonnel, Franck
    Robert, Caroline
    Mussini, Charlotte
    Bellanger, Christophe
    Meyer, Antoine
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (04)
  • [48] IMMUNE-RELATED ADVERSE EVENTS FOLLOWING IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Zhu, Kaiwen
    Niu, Chengu
    Liu, Hongli
    Okolo, Patrick
    GASTROENTEROLOGY, 2023, 164 (06) : S1431 - S1432
  • [49] Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
    Cheema, Parneet K.
    Iafolla, Marco A. J.
    Abdel-Qadir, Husam
    Bellini, Andrew B.
    Chatur, Nazira
    Chandok, Natasha
    Comondore, Vikram R.
    Cunningham, Morven
    Halperin, Ilana
    Hu, Anne B.
    Jaskolka, Diana
    Darvish-Kazem, Saeed
    Khandaker, Masud H.
    Kitchlu, Abhijat
    Sachdeva, Jasdip S.
    Shapera, Shane
    Woolnough, Nicholas R. J.
    Nematollahi, Massey
    CURRENT ONCOLOGY, 2024, 31 (10) : 6356 - 6383
  • [50] Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update
    Hiroki Nagai
    Manabu Muto
    International Journal of Clinical Oncology, 2018, 23 : 410 - 420